BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 16 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 16 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 16 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 17 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 17 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 18 hours ago Atmus Welcomes Heath Sharp to Board of Directors 20 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 20 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 3 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 3 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 16 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 16 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 16 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 17 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 17 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 18 hours ago Atmus Welcomes Heath Sharp to Board of Directors 20 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 20 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 3 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 3 days ago
ADVERTISEMENT
AlphaGraphs

CME Earnings: Highlights of CME Group’s Q2 2023 report

Derivatives marketplace CME Group Inc. (NASDAQ: CME) on Wednesday reported higher earnings and revenues for the second quarter of 2023. CME Group’s second-quarter revenues increased 10% year-over-year to $1.36 billion, with all three operating segments registering strong growth. Net income, adjusted for one-off items, increased 17% year-over-year to $2.30 per share during the three-month period. […]

July 26, 2023 1 min read

Derivatives marketplace CME Group Inc. (NASDAQ: CME) on Wednesday reported higher earnings and revenues for the second quarter of 2023.

CME Group Q2 2023 earnings infographic

CME Group’s second-quarter revenues increased 10% year-over-year to $1.36 billion, with all three operating segments registering strong growth.

Net income, adjusted for one-off items, increased 17% year-over-year to $2.30 per share during the three-month period. Unadjusted earnings were $767.8 million or $2.14 per share, which is higher than the profit generated in the prior-year period.

“Given ongoing uncertainty in both macroeconomic and geopolitical environments, market participants continued turning to CME Group risk management products and services in Q2, with particularly noteworthy volume increases across our interest rate, commodity, and options contracts,” said CME’s CEO Terry Duffy.

ADVERTISEMENT
ADVERTISEMENT